Name: Diagnostic and Therapeutic Advances in Alzheimer's Disease (en Inglés)
Price: 135280.00 CLP
Availability: InStock
Author: Poole, Elena
ISBN: 9781639276585

portada Diagnostic and Therapeutic Advances in Alzheimer's Disease (en Inglés)

Formato

Libro Físico

Ilustrado por

Elena Poole

Editorial

American Medical Publishers

Autor

Poole, Elena

Idioma

Inglés

N° páginas

239

Encuadernación

Tapa Dura

Dimensiones

27.9 x 21.6 x 1.4 cm

Peso

0.84 kg.

ISBN13

9781639276585

Categorías

Neurología y neurofisiología clínicas
Psiquiatría
Alzheimer y a la demencia

Diagnostic and Therapeutic Advances in Alzheimer's Disease (en Inglés)

Elena Poole (Ilustrado por) · American Medical Publishers · Tapa Dura

Libro Físico

$ 135.280

$ 270.550

Ahorras: $ 135.270

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 05 de Junio y el Lunes 17 de Junio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Diagnostic and Therapeutic Advances in Alzheimer's Disease (en Inglés)"

Alzheimer's disease (AD) refers to a type of neurologic condition, which causes the brain to shrink and brain cells to die over time. AD is the most frequent form of dementia in which a progressive loss in social, cognitive and behavioral abilities occurs that impairs a person's capacity to operate independently. The primary symptom of AD is forgetting recent events or discussions. A person with AD will have severe memory impairment, while losing the capacity to perform daily tasks, as the disease progress. Drug development for AD relies heavily on biomarkers and they can also be used to facilitate diagnosis, safety monitoring, demonstrating target engagement and supporting the modification of disease. AD is incurable due to its multifactorial and complex nature. Biomarkers aid in characterizing the baseline state, a therapy response or a disease process. This book is compiled in such a manner, that it will provide in-depth knowledge about the assessment and management of Alzheimer's disease. It presents researches and studies performed by experts across the globe.